Vaso Corp. (VASO)
OTHER OTC:VASO
Top Page
Vaso
(OTC:VASO)
Select Model
Select Model
Rating:57Neutral
Price Target:
$0.18
▲(2.94% Upside)
Action:ReiteratedDate:04/01/26
The score is primarily driven by mixed financial performance: strong balance-sheet leverage and positive/free cash flow support resilience, but the latest-year swing to a net loss reduces confidence in near-term earnings quality. Technical indicators are broadly neutral with slightly negative momentum, while valuation is pressured by loss-making results (negative P/E).
Positive Factors
Conservative balance sheet
Low reported debt (roughly 6% of equity in 2025) and a steadily expanding asset/equity base provide durable financial flexibility. This reduces refinancing and liquidity risk, enabling the firm to fund operations or strategic initiatives over the next several quarters despite profit swings.
Negative Factors
Swing to net loss
A meaningful shift from low positive margins to a -4.7% net margin signals rising costs or operating inefficiency. This deterioration weakens earnings quality and increases the risk that profitability will remain pressured for several quarters absent structural cost reductions or revenue recovery.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Low reported debt (roughly 6% of equity in 2025) and a steadily expanding asset/equity base provide durable financial flexibility. This reduces refinancing and liquidity risk, enabling the firm to fund operations or strategic initiatives over the next several quarters despite profit swings.
Read all positive factors
Vaso (VASO) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$28.68M
Dividend YieldN/A
Average Volume (3M)98.46K
Price to Earnings (P/E)6.8
Beta (1Y)0.26
Revenue Growth9.14%
EPS GrowthN/A
CountryUS
Employees298
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)<0.01
Shares Outstanding175,953,030
10 Day Avg. Volume66,687
30 Day Avg. Volume98,461
Financial Highlights & Ratios
PEG Ratio-0.11
Price to Book (P/B)1.04
Price to Sales (P/S)0.35
P/FCF Ratio3.68
Enterprise Value/Market Cap-0.16
Enterprise Value/Revenue-0.05
Enterprise Value/Gross Profit-0.08
Enterprise Value/Ebitda10.78
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Vaso Business Overview & Revenue Model
Company Description
Vaso (VASO) is a technology-driven company focused on providing innovative solutions in the healthcare and medical sectors. The company specializes in developing advanced telehealth platforms and medical products that enhance patient care and stre...
Vaso Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
78
Positive
Cash Flow
71
Positive
| Breakdown | Dec 2025 | Mar 2025 | Mar 2024 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 89.10M | 86.77M | 81.02M | 80.02M | 75.58M |
| Gross Profit | 54.67M | 52.05M | 50.59M | 48.48M | 43.13M |
| EBITDA | -423.00K | 2.10M | 5.95M | 8.38M | 6.66M |
| Net Income | 1.57M | 951.00K | 4.80M | 11.87M | 6.10M |
Balance Sheet | |||||
| Total Assets | 88.35M | 82.94M | 75.76M | 72.66M | 52.36M |
| Cash, Cash Equivalents and Short-Term Investments | 35.05M | 26.27M | 25.32M | 20.32M | 6.65M |
| Total Debt | 1.81M | 2.38M | 2.06M | 1.81M | 1.39M |
| Total Liabilities | 58.92M | 55.24M | 48.91M | 49.78M | 41.05M |
| Stockholders Equity | 29.43M | 27.70M | 26.84M | 22.88M | 11.31M |
Cash Flow | |||||
| Free Cash Flow | 8.35M | 1.83M | 4.57M | 13.85M | 7.40M |
| Operating Cash Flow | 9.27M | 3.28M | 5.30M | 14.42M | 7.82M |
| Investing Cash Flow | -725.00K | 11.73M | -5.66M | -8.42M | -260.00K |
| Financing Cash Flow | 248.00K | -89.00K | -134.00K | -230.00K | -8.33M |
Vaso Technical Analysis
Negative
0.17
Price Trends
0.17
Negative
0.17
Negative
0.14
Positive
Market Momentum
>-0.01
Positive
37.41
Neutral
11.63
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For VASO, the sentiment is Negative. The current price of 0.17 is above the 20-day moving average (MA) of 0.17, below the 50-day MA of 0.17, and above the 200-day MA of 0.14, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 37.41 is Neutral, neither overbought nor oversold. The STOCH value of 11.63 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for VASO.
Vaso Risk Analysis
Vaso disclosed 32 risk factors in its most recent earnings report. Vaso reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Vaso Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
57 Neutral | $28.68M | 6.80 | 9.49% | ― | 9.14% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
44 Neutral | $47.25M | -3.85 | -571.06% | ― | ― | 4.31% | |
42 Neutral | $10.89M | -0.51 | 336.68% | ― | 187.24% | 82.90% | |
41 Neutral | $2.77M | >-0.01 | -112.81% | ― | -21.88% | 68.40% |
* Healthcare Sector Average
VASO
Vaso
0.16
0.03
25.38%
HCTI
Healthcare Triangle
2.40
-3,309.80
-99.93%
BEAT
HeartBeam
1.15
-0.53
-31.55%
VSEE
VSee Health
0.23
-0.82
-78.01%
BFRG
BullFrog AI Holdings, Inc.
0.89
-1.22
-57.86%
MGRX
Mangoceuticals, Inc.
0.34
-1.22
-78.27%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.